Search

everythinglearnresearchcommunity

for

Search:↓

Treatment with a hormone agonist can reduce excess male hormones in postmenopausal women without surgery.

Some medicines can reduce excessive hair growth in women, but more research is needed to compare treatments and consider side effects.

Some antiandrogens may lower testosterone better than others, but it's unclear which is best for feminization in transgender women; more research is needed.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

For women with moderate to severe unwanted hair growth or acne, birth control pills are the first choice, with other medications like cyproterone, spironolactone, flutamide, or finasteride as alternatives, and permanent hair removal should be done with electrolysis or laser.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

The nafarelin test can reliably distinguish between gonadotropin deficiency and delayed puberty in teenage boys.

Most patients improved with oral contraceptives, but some needed additional treatment.

Most women with too much androgens have PCOS, which can be managed with birth control pills, medication for hair growth, and fertility treatments, and losing weight helps too.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

The combination therapy reduced hirsutism in women with PCOD and was well-tolerated.

PCOS treatment focuses on inducing ovulation, reducing androgens, and managing long-term health risks with medications and lifestyle changes.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Low prolactin levels in PCOS can cause metabolic problems like insulin resistance and obesity.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.

Male hormones and their interactions are crucial for male sexual development and characteristics.

The document concludes that treatment for excessive hair growth depends on the cause, with options including hair removal methods and medications like anti-androgens or insulin-sensitizing drugs.

Elagolix did not effectively treat polycystic ovary syndrome.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.